Status:
COMPLETED
Pilot Evaluation of FAMCOPE-ICU (Family Coping and Emotion Regulation Tool in the ICU)
Lead Sponsor:
University Hospitals Cleveland Medical Center
Collaborating Sponsors:
National Center for Advancing Translational Sciences (NCATS)
Conditions:
Emotion Regulation
Coping Skills
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
Having a family member or loved one in the ICU can be a very stressful experience. The investigators have created a tablet-based tool (FAMCOPE-ICU) that is designed to help people in this position cop...
Eligibility Criteria
Inclusion
- Patient
- 18-89 years old
- Intensive Care Unit (ICU) length of stay (LOS) \>= 48 hours
- No anticipated ICU LOS for next 24 hours
- Unable to make healthcare decisions
- Family Inclusion Criteria
- Identified by critical care team as legally authorized representative (LAR)
- Able to speak or comprehend English
- \>= 18 years old
- Patient
Exclusion
- Less than 18 years or older than 89 years
- ICU LOS \< 48 hours
- Anticipated ICU discharge within next 24 hours
- Able to make healthcare decisions
- Family Exclusion Criteria
- Not identified by critical care team as the LAR
- Unable to speak or comprehend English
- \< 18 years old
Key Trial Info
Start Date :
August 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 27 2023
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT05408468
Start Date
August 15 2022
End Date
July 27 2023
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States, 44106